source
- STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ caseThe Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.STAT · 1mo ago↗ source
- Acting FDA commissioner pledges to prevent political interference in rare disease meetingExecutives from 15 rare disease-focused nonprofits met on Wednesday with acting FDA Commissioner Kyle Diamantas and senior staff. In the meeting, Diamantas made it clear he's headed in a different…Endpoints · 1mo ago↗ source
- STAT+: For pancreatic cancer patients, an exciting drug can feel out of reachFor pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…